Kiri Duke-Rosati suffers from cerebral adrenoleukodystrophy, a deadly metabolic disorder. 13,000 people have swabbed to find a stem cell match for Kiri and others. Kiri's slower-than-expected disease ...

Add Yahoo as a preferred source to see more of our stories on Google. Kiri Duke-Rosati, 3, leaps off the couch as he plays “keepy uppy” with a balloon in his home in Holladay on Monday, Aug. 4, 2025.

MMUD PBSC transplantation with <7/8 HLA matching showed comparable 1-year overall survival to 7/8 matching, with rates of 85.6% and 78.6%, respectively. The 1-year GVHD-free, relapse-free survival ...

Introduction: Donor–recipient compatibility remains a central determinant of transplant success, yet conventional antigen-level human leukocyte antigen (HLA) matching provides limited resolution for ...

New results from the Phase II ACCESS trial represent a significant milestone in solving one of transplant medicine’s biggest challenges: finding a donor for every patient in need of a blood stem cell ...

ORLANDO -- Stem-cell transplants with mismatched unrelated donors (MMUDs) beyond a single HLA locus (<7/8) had 1-year survival similar to better-matched donors, suggesting significant potential to ...

Please provide your email address to receive an email when new articles are posted on . Patients who received stem cell grafts from unrelated donors matched at as few as 4/8 HLA markers achieved ...

The selection of suitable donors is crucial for the long-term recovery of patients after an allogeneic hematopoietic stem cell transplantation (allo-HSCT). Primarily, the transplantation from a ...

Real Madrid suffered their first Champions League loss and just their second of the season in all competitions, losing 1-0 to Liverpool at Anfield. A second-half header from Alexis Mac Allister was ...

Data demonstrate efficacy and durability of vispa-cel, an allogeneic anti-CD19 CAR-T cell therapy, are on par with autologous CAR-T cell therapies in the confirmatory cohort (N=22) and with ...